Fol. Biol. 2007, 53, 66-68
https://doi.org/10.14712/fb2007053020066
Collagen Degradation Products and Proinfiammatory Cytokines in Systemic and Localized Scleroderma
References
1. , R., Stork, J., Pesakova, V., Stanova, A., Hulejova, H., Rysova, I., Zatloukalova, A., Pourova, L. (2005) Clinical correlations of potential activity markers in systemic sclerosis. Ann. N. Y. Acad. Sci. 1051, 404-412.
<https://doi.org/10.1196/annals.1361.082>
2. , J., Neess, C. M., Gaber, Y., Sobhi, H., Notbohm, H., Hunzelmann, N., Fietzek, P. P., Scharffetter-Kochanek, K. (2001) Different pattern of collagen cross-links in two sclerotic skin diseases: lipodermatosclerosis and circumscribed scleroderma. J. Invest. Dermatol. 117, 269-273.
<https://doi.org/10.1046/j.0022-202x.2001.01414.x>
3. , E. M., Raychaudburi, S. P. (1999) Is psoriasis a neuroimmunologic disease? Int. J. Derm. 38, 12-15.
<https://doi.org/10.1046/j.1365-4362.1999.00635.x>
4. , R., Czirják, L., Lukáč, J., Stančíková, M., Rovenský J. (2001a) Increased urinary pyridinoline cross-link compound of collagen in patients with systemic sclerosis and Raynaud's phenomenon. Rheumatology 40, 140-146.
<https://doi.org/10.1093/rheumatology/40.2.140>
5. , R., Bely, M., Stancikova, M., Rovensky, J. (2001b) Evidence for increased pyridinoline concentration in fibrotic tissues in diffuse systemic sclerosis. Clin. Exp. Dermatol. 26, 545-547.
<https://doi.org/10.1046/j.1365-2230.2001.00886.x>
6. Jablonska, S. (1988) Localized scleroderma. In: Systemic Sclerosis, eds. Jayson, M. I. V., Black, C. M., pp 303-318, Chichester, Willey, London.
7. , M. B., LeRoy, E. C. (1989) Interleukin-2 in scleroderma: correlation of serum levels with extent of skin involvement and disease duration. Ann. Intern. Med. 110, 446-450.
<https://doi.org/10.7326/0003-4819-110-6-446>
8. , E. C., Black, C. M., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T. A. L., Jr., Wollheim, F. (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202-205.
9. Medsger, T. A. (1985) Comment on scleroderma criteria cooperative study. In: Systemic Sclerosis (Scleroderma), eds. Black, C. M., Myers, A. R. pp. 235-249, Gower Med., New York.
10. , J. C. (1999) Which T cells cause psoriasis? Clin. Exp. Dermatol. 24, 291-295.
<https://doi.org/10.1046/j.1365-2230.1999.00483.x>
11. , P. M. (2000) The complexity and redundancy of epithelial barrier function. J. Cell. Biol. 151, F5-F7.
<https://doi.org/10.1083/jcb.151.2.F5>
12. , P. J., Korn, J. H., North, R., Lally, E. V., Miller, L. C., Tucker, L. B., Strongwater, S., Franzblau, C. (1995) Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma. Arthritis Rheum. 38, 517-524.
<https://doi.org/10.1002/art.1780380409>
13. , J. (1991) Classification of sclerodermia circumscripta. Čs. Derm. 66, 331-335 (in Czech).
